Brainstim Centers

What Brainstim Centers does

BrainStim Centers, Inc. is a privately held, California-incorporated outpatient healthcare practice founded in 2020 that delivers personalized Transcranial Magnetic Stimulation (TMS) therapy. The company operates four treatment centers in Valencia, Calabasas, Van Nuys, and Lancaster, California; one international treatment center in Cancun, Mexico; and six TBI diagnostic centers across California. Its service is anchored on the Nexstim SmartFocus neuro-navigation TMS platform, of which the practice holds 6 of fewer than 35 units installed in the USA, combined with patient-specific brain MRI and Quantitative EEG (qEEG) alpha peak frequency mapping to individualize treatment targeting.

The clinical offering spans a broad protocol stack including Standard Protocol TMS (rTMS), Neuro-Navigated TMS, Theta Burst, Accelerated TMS, and MeRT (Magnetic e-Resonance Therapy), applied across a wide indication portfolio: treatment-resistant depression, anxiety, OCD, PTSD, ADHD, autism spectrum disorder, TBI/concussion, chronic pain, tinnitus, sleep disorders, substance use disorder, and a preventive brain optimization service. BrainStim claims an 80-90% effectiveness rate for personalized brain-navigated TMS versus 40-60% at non-personalized centers. Patient access is enabled through a multi-channel motion combining physician and psychiatrist referrals, insurance authorization (particularly for treatment-resistant depression), self-referral, and a dedicated military/veteran outreach program.

The business is a direct-to-consumer professional services practice. Revenue is generated per TMS treatment session (typical courses around 36 sessions) plus diagnostic services including MRI, qEEG, and TBI assessments, with insurance coverage the dominant billing mechanism for eligible indications. Pricing is not publicly disclosed. The practice is neurosurgeon-led (Dr. Mark Liker) and operates with 11-50 employees, with no disclosed institutional investors, funding rounds, or parent company.

Name

Brainstim Centers

Legal name

BrainStim Centers, Inc.

Website

https://brainstimcenters.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

BrainStim Centers is a California-based outpatient practice delivering personalized, MRI- and qEEG-guided neuro-navigated TMS therapy for treatment-resistant depression, PTSD, OCD, TBI, autism, ADHD, chronic pain, and related conditions, operating four California treatment centers, a Cancun site, and six TBI diagnostic centers.

Ownership category

akta.pro rank

Product category

Mental Health Treatment Services

NAICS

Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

akta.pro secondary industries

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

Keywords

• TMS therapy services
• Brain stimulation treatment
• Mental health treatment
• Neuro navigation technology
• Depression treatment

Headquarters

HQ city

Santa Clarita

HQ country

United States

HQ region

North America

Offices11 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. TMS Therapy Treatment Sessions: Revenue generated from providing transcranial magnetic stimulation therapy sessions. Treatment typically involves multiple sessions (often 36 sessions) administered over several weeks. Insurance often covers the cost for treatment-resistant depression and other covered conditions.
2. Diagnostic Services: Revenue from diagnostic assessments including brain MRI scans, qEEG brain mapping, and initial consultation assessments used to determine treatment protocols.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

BrainStim Centers provides personalized, non-invasive Transcranial Magnetic Stimulation (TMS) therapy using Nexstim SmartFocus neuro-navigated systems, with treatment protocols individualized to each patient via MRI brain imaging and qEEG biomarker analysis. Its services span multiple TMS protocols (Standard rTMS, Neuro Navigated TMS, Theta Burst, Accelerated TMS, MeRT) and a portfolio of condition-specific treatments including treatment-resistant depression, anxiety, PTSD, OCD, TBI, autism, ADHD, tinnitus, chronic pain, sleep disorders, and substance use disorder, supplemented by TBI diagnostic services.

Product overview

BrainStim Centers offers a unified platform of personalized neuro-navigated TMS (Transcranial Magnetic Stimulation) therapy treatments with multiple protocols and diagnostic services. The core offering includes Standard Protocol TMS (rTMS), Neuro Navigated TMS, Theta Burst TMS, Accelerated TMS, and MeRT (Magnetic e-Resonance Therapy), each representing different treatment protocols and approaches. These are supported by comprehensive diagnostic services including qEEG brain mapping, MRI imaging, and TBI diagnostics. The company treats a portfolio of neurological and mental health conditions including Depression, Anxiety, PTSD, OCD, Sleep Disorders, Autism, TBI/Brain Injury, Tinnitus, Chronic Pain, ADHD, Brain Optimization, and Substance Use Disorder, with treatment centers in California (Van Nuys, Calabasas, Valencia, Lancaster) and Cancun, Mexico, plus diagnostic centers throughout California.

Differentiator

Problem solved

Functional benefit

Products and services

• Standard Protocol TMS (rTMS) Traditional repetitive Transcranial Magnetic Stimulation using standardized protocols to deliver magnetic pulses to targeted brain areas for mood regulation; offered to patients with treatment-resistant depression and related conditions.
• Neuro Navigated TMS MRI-guided personalized TMS treatment using advanced brain imaging to precisely target treatment locations based on individual brain anatomy and biomarkers; for patients who do not respond to standardized protocols.
• Theta Burst TMS Accelerated TMS protocol using burst stimulation patterns designed to achieve similar or enhanced effects in shorter treatment sessions.
• Accelerated TMS Intensive TMS treatment delivering multiple sessions per day over 4-5 days for faster symptom relief compared to traditional protocols.
• MeRT (Magnetic e-Resonance Therapy) Personalized brain treatment combining TMS with EEG analysis to customize treatment based on individual brainwave patterns for conditions like depression, PTSD, and autism.
• Personalized TMS Therapy for Mental Health and Neurological Conditions Condition-specific TMS therapy covering treatment-resistant depression, anxiety, PTSD, OCD, autism, ADHD, sleep disorders, tinnitus, chronic pain, cognitive decline / brain optimization, and substance use disorder, with protocols tailored to each indication using MRI and qEEG biomarkers.
• TBI Diagnostics Diagnostic imaging and assessment services for traumatic brain injuries provided across multiple California diagnostic center locations.

Quantifiable outcome

• 80-90% effective rate for personalized brain-navigated TMS vs 40-60% at other centers
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• NexstimcoreTechnology or IntegrationNexstim provides the SmartFocus neuro-navigation TMS system used at BrainStim Centers. This is the advanced technology platform that enables MRI-guided, personalized TMS treatment. BrainStim Centers reports having 6 of fewer than 35 such machines in the USA.

Scale indicators3 records

Recent moves1 record

Expansion highlights6 records

Direct peers

• TMS Centers of America: Multi-state TMS clinic operator providing non-navigated rTMS for depression and other psychiatric indications. Comparable to BrainStim as a competing outpatient TMS clinic chain competing for the same referral and payor relationships.
• APOLLO TMS: US operator of TMS clinics offering treatment for depression, anxiety, PTSD and OCD. Comparable to BrainStim as a competing outpatient TMS clinic chain targeting similar referral sources and patient populations.
• Achieve TMS: US TMS clinic network operating in the western US with a similar referral-driven, insurance-billing model. Comparable to BrainStim in offering rTMS for depression, anxiety, OCD and PTSD across multiple clinic sites.
• Wave Neuroscience (MeRT): Provider of Magnetic e-Resonance Therapy (MeRT), which combines qEEG-guided TMS protocols. Directly comparable to BrainStim because BrainStim also offers MeRT and shares the same qEEG-personalized treatment approach for depression, PTSD, autism and TBI.
• Greenbrook TMS: National TMS clinic chain operating 100+ centers across the US, offering rTMS for depression, OCD and other indications. Direct peer to BrainStim as both run multi-site TMS treatment practices targeting treatment-resistant mental health conditions.

Broad incumbents

• Magstim: UK-based manufacturer of TMS stimulators and coils used in clinical and research settings. Comparable as a TMS equipment vendor operating in the same neuromodulation ecosystem that supplies BrainStim-adjacent providers.
• Neuronetics: Manufacturer of the NeuroStar TMS system and operator of affiliated treatment centers. Comparable as the dominant incumbent defining the standard TMS category that BrainStim's personalized Nexstim-based offering seeks to differentiate from.
• Brainsway: Israel-based developer of Deep TMS systems (H-coil) with FDA-cleared indications in depression, OCD, and smoking cessation. Comparable to BrainStim as an established TMS technology and treatment provider in overlapping neurological and psychiatric indications.

Others

• Cerebral: National telehealth mental health platform providing online psychiatry and therapy, including for treatment-resistant depression. Comparable as a competing channel for patients seeking non-traditional depression care, though it uses a digital delivery model rather than in-clinic TMS.

Emerging players

• eNeura (Cefaly/SAINT TMS): Developer of neuromodulation devices including transcranial magnetic stimulation for migraine and depression (SAINT protocol). Comparable as a smaller, specialized player in TMS-style brain stimulation, partially overlapping with BrainStim's neurological indication set.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BrainStimCentersInc
• Xx.com/BrainStimC
• LinkedInlinkedin.com/company/brainstim-centers

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brainstim Centers